Save information for later
Sign Up

Learn About Progressive Supranuclear Palsy Atypical

What are the alternative names for Progressive Supranuclear Palsy Atypical?
  • Progressive supranuclear palsy atypical
  • Atypical PSP
Who are the top Progressive Supranuclear Palsy Atypical Local Doctors?
Alex Pantelyat
Elite in Progressive Supranuclear Palsy Atypical
Elite in Progressive Supranuclear Palsy Atypical

Johns Hopkins Outpatient Center

Baltimore, MD 
Languages Spoken:
English, Russian, Spanish, Ukrainian

Dr. Alexander Pantelyat cares for patients with movement disorders such as Parkinson's disease and related syndromes, essential tremor, dystonia, chorea and normal pressure hydrocephalus. He also provides botulinum toxin injections for movement disorders and is involved in deep brain stimulation programming and intraoperative neurophysiological monitoring.His research explores atypical parkinsonian disorders, such as dementia with Lewy bodies, progressive supranuclear palsy, corticobasal syndrome/degeneration and multiple system atrophy; cognitive aspects of movement disorders; and music-based rehabilitation of neurodegenerative diseases.Dr. Pantelyat earned his medical degree from Temple University School of Medicine in Philadelphia, where he was elected a member of the Alpha Omega Alpha Honor Medical Society and received the Matthew T. Moore Prize in Neurology. He completed his residency training in Neurology ​at the University of Pennsylvania in Philadelphia, and a fellowship in movement disorders at the University of Pennsylvania/Philadelphia VA Medical Center. As part of his fellowship, Dr. Pantelyat also completed the Clinical Research Certificate Program at the Center for Clinical Epidemiology and Biostatistics. He is a 2013 American Academy of Neurology Palatucci Advocacy Leader and grant recipient. Dr. Pantelyat is rated as an Elite provider by MediFind in the treatment of Progressive Supranuclear Palsy Atypical. His top areas of expertise are Progressive Supranuclear Palsy, Progressive Supranuclear Palsy Atypical, Supranuclear Ophthalmoplegia, and Corticobasal Degeneration.

Kyle T. Mitchell
Distinguished in Progressive Supranuclear Palsy Atypical
Distinguished in Progressive Supranuclear Palsy Atypical

Duke Neurology Morreene Road

932 Morreene Rd, 
Durham, NC 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Kyle Mitchell is a Neurologist in Durham, North Carolina. Dr. Mitchell is rated as a Distinguished provider by MediFind in the treatment of Progressive Supranuclear Palsy Atypical. His top areas of expertise are Progressive Supranuclear Palsy, Supranuclear Ocular Palsy, Progressive Supranuclear Palsy Atypical, Supranuclear Ophthalmoplegia, and Deep Brain Stimulation. Dr. Mitchell is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Sneha A. Mantri
Distinguished in Progressive Supranuclear Palsy Atypical
Distinguished in Progressive Supranuclear Palsy Atypical

Duke Neurology Morreene Road

932 Morreene Rd, 
Durham, NC 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Sneha Mantri is a Neurologist in Durham, North Carolina. Dr. Mantri is rated as a Distinguished provider by MediFind in the treatment of Progressive Supranuclear Palsy Atypical. Her top areas of expertise are Parkinson's Disease, Movement Disorders, Supranuclear Ophthalmoplegia, Progressive Supranuclear Palsy, and Deep Brain Stimulation. Dr. Mantri is currently accepting new patients.

What are the latest Progressive Supranuclear Palsy Atypical Clinical Trials?
A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy

Summary: This study is designed to learn more about overall tau burden in the brain of patients with Progressive Supranuclear Palsy (PSP).

Match to trials
Find the right clinical trials for you in under a minute
Get started
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Background: Neurodegenerative disorders can lead to problems in movement or memory. Some can cause abnormal proteins to build up in brain cells. Researchers want to understand whether these diseases have related causes or risk factors.

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center